Tag: biosimilar pharmacovigilance
Adverse Event Monitoring for Biosimilars: How Safety Surveillance Works Today
Biosimilars require specialized safety monitoring because they're not identical to reference biologics. Learn how adverse event reporting, traceability, and active surveillance systems ensure patient safety while supporting cost-effective treatment options.
DetailRelated Posts
